Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NewAmsterdam Pharma Announced Dosing Of The First Patient And Initiation Of TANDEM Phase 3 Trial To Evaluate Obicetrapib And Ezetimibe FDC In Adult Patients With Heterozygous Familial Hypercholesterolemia And/Or Atherosclerotic Cardiovascular Disease

Author: Benzinga Newsdesk | March 12, 2024 08:13am

Posted In: NAMS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist